Literature DB >> 30367484

Exercise ameliorates insulin resistance via regulating TGFβ-activated kinase 1 (TAK1)-mediated insulin signaling in liver of high-fat diet-induced obese rats.

Yong Zhang1, Jianyong Wan1, Zhen Xu2, Tianmiao Hua3, Qingyan Sun1.   

Abstract

Exercise is an effective therapy for insulin resistance. However, the underlying mechanism remains to be elucidated. Previous research demonstrated that TGFβ-activated kinase 1 (TAK1)-dependent signaling plays a crucial character in hepatic insulin resistance. Hepatic ubiquitin specific protease 4 (USP4), USP18, and dual-specificity phosphatases 14 (DUSP14) can suppress TAK1 phosphorylation, besides tumor necrosis factor receptor-associated factor 3 (TRAF3) and tripartite motif 8 (TRIM8) promote its phosphorylation. In this study, we tried to verify our hypothesis that exercise improves insulin resistance in high-fat diet (HFD)-induced obese (DIO) rats via regulating the TAK1 dependent signaling and TAK1 regulators in liver. Forty male Sprague-Dawley rats were randomized into four groups (n = 10): standard diet and sedentary as normal control; fed on HFD and DIO-sedentary; fed on HFD and DIO-chronic exercise; and fed on HFD and DIO-acute exercise. HFD feeding resulted in increased body weight, visceral fat mass, serum FFAs and hepatic lipid deposition, but decreased hepatic glycogen content and insulin sensitivity. Moreover, hepatic TRAF3 and TRIM8 protein levels increased, whereas USP4, USP18, and DUSP14 protein levels were decreased under obese status, which resulted in enhanced TAK1 phosphorylation and impaired insulin signaling. Exercise training, containing chronic and acute mode, both ameliorated insulin resistance. Meanwhile, decreased TAK1, c-Jun N-terminal kinase 1 (JNK1), and insulin receptor substrate 1 (IRS1) phosphorylation enhanced Akt phosphorylation in liver. Moreover, exercise enhanced USP4 and DUSP14 protein levels, whereas decreased TRIM8 protein levels in obese rats' liver. These results showed that exercise triggered a crucial modulation in TAK1-dependent signaling and its regulators in obese rats' liver, and distinct improvement in insulin sensitivity, which provide new insights into the mechanism by which physical exercise improves insulin resistance.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  TGFβ-activated kinase 1 (TAK1) phosphorylation; exercise training; insulin resistance (IR); insulin signaling

Mesh:

Substances:

Year:  2018        PMID: 30367484     DOI: 10.1002/jcp.27508

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  4 in total

1.  A Comparison Study on the Therapeutic Effect of High Protein Diets Based on Pork Protein versus Soybean Protein on Obese Mice.

Authors:  Songsong Jiang; Shanshan Ji; Xinlei Tang; Tao Wang; Hengpeng Wang; Xiangren Meng
Journal:  Foods       Date:  2022-04-24

2.  Short-Term Strength Exercise Reduces Hepatic Insulin Resistance in Obese Mice by Reducing PTP1B Content, Regardless of Changes in Body Weight.

Authors:  Kellen Cristina da Cruz Rodrigues; Rodrigo Martins Pereira; Guilherme Francisco Peruca; Lucas Wesley Torres Barbosa; Marcella Ramos Sant'Ana; Vitor Rosetto Muñoz; Ana Paula Morelli; Fernando Moreira Simabuco; Adelino Sanchez Ramos da Silva; Dennys Esper Cintra; Eduardo Rochete Ropelle; José Rodrigo Pauli; Leandro Pereira de Moura
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

3.  HIV antiretroviral drugs, dolutegravir, maraviroc and ritonavir-boosted atazanavir use different pathways to affect inflammation, senescence and insulin sensitivity in human coronary endothelial cells.

Authors:  Martine Auclair; Anne-Claire Guénantin; Soraya Fellahi; Marie Garcia; Jacqueline Capeau
Journal:  PLoS One       Date:  2020-01-23       Impact factor: 3.240

4.  Ubiquitously specific protease 4 inhibitor-Vialinin A attenuates inflammation and fibrosis in S100-induced hepatitis mice through Rheb/mTOR signalling.

Authors:  Jie Xu; Dazhi Chen; Lanling Jin; Zhengkang Chen; Yulu Tu; Xiaozhe Huang; Feiben Xue; Jialu Xu; Mingzhuan Chen; Xiaodong Wang; Yongping Chen
Journal:  J Cell Mol Med       Date:  2020-12-09       Impact factor: 5.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.